Magnesium Sulfate Administration Guidelines

Dosing by Clinical Indication

• The American College of Cardiology recommends a loading dose of 4-6g IV magnesium sulfate for preeclampsia/eclampsia, administered over 20-30 minutes, followed by a maintenance infusion of 1-2g/hour 1
• For severe refractory asthma, 2g IV magnesium sulfate diluted to 20% or less concentration, administered over 20 minutes, is recommended by the American Heart Association 2
• The American Academy of Pediatrics recommends 2g IV magnesium sulfate as first-line therapy for Torsades de Pointes, regardless of serum magnesium level 3

Important Precautions

• The American Academy of Pediatrics advises having calcium immediately available to counteract magnesium toxicity 3

Magnesium Sulfate IV Administration Guidelines

Introduction to Magnesium Sulfate Administration

• The American Heart Association recommends administering 1-2 g IV over 15 minutes for acute hypomagnesemia, followed by maintenance infusion of 1 g/hour for 24 hours if needed, with common side effects including flushing, hypotension, and bradycardia 4

Dosing and Administration

• For polymorphic VT associated with QT prolongation (torsades de pointes): 1-2 g IV over 15 minutes, as recommended by the American College of Cardiology 4, 5
• Maintenance therapy should be titrated based on serum magnesium levels, with target range of 1.3-2.2 mEq/L, according to the American Heart Association 5

Magnesium Sulfate Administration Protocol

Administration by Clinical Indication

• The International Society for the Study of Hypertension in Pregnancy recommends using the dosing regimens from the Eclampsia and MAGPIE trials, which demonstrated approximately 50% reduction in seizure risk, and suggests stopping magnesium sulfate after 8 g predelivery may be reasonable in select populations 6
• In perioperative use for VATS, a regimen of 50 mg/kg IV bolus over 10 minutes after intubation, followed by continuous infusion of 50 mg/kg/hour until end of surgery, reduced postoperative opioid requirements and improved pulmonary function 7

Magnesium Sulfate Administration Guidelines

Standard Duration and Dosing

• The American College of Cardiology recommends continuing magnesium sulfate for 24 hours postpartum after delivery as the standard recommendation for preeclampsia/eclampsia 8, 9
• Alternative approach: May discontinue magnesium sulfate after administering at least 8 grams predelivery in select populations, though this requires consideration of local postpartum eclampsia incidence 8, 9
• Clinical reasoning suggests that the 24-hour postpartum duration remains the guideline-recommended standard because eclampsia can occur postpartum, and while Latin American data suggests 8 grams predelivery may suffice, this has not been validated across all populations 8, 9
• Do not continue magnesium sulfate beyond 24 hours postpartum without clear indication, as most eclampsia risk resolves by this time 8, 9

Magnesium Sulfate Administration for Eclampsia Prevention and Treatment

Introduction to Pritchard Regimen

• The American College of Cardiology recommends a 14-gram loading dose of magnesium sulfate, consisting of 4 grams IV and 10 grams IM, for eclampsia prevention and treatment, with a maintenance dose of 5 grams IM every 4 hours for 24 hours 10, 11

Loading Dose Protocol

• The Pritchard regimen involves a loading dose of 14 grams administered simultaneously through two routes, with 4 grams IV and 10 grams IM, split as 5 grams in each buttock 10, 11
• The loading dose includes 10 grams intramuscular, split as 5 grams in one buttock and 5 grams in the other buttock 10

Maintenance Dose Protocol

• The maintenance dose consists of 5 grams IM every 4 hours for 24 hours total duration 10
• The maintenance dose should be administered in alternating buttocks with each dose 10

Clinical Context and Comparison

• The Pritchard regimen is recommended when IV infusion pumps are unavailable or IV access is limited, as it was validated in the landmark MAGPIE trial, demonstrating approximately 50% reduction in seizure risk 10, 11
• The Pritchard regimen is an alternative to the IV-only protocol, which is preferred when IV access and infusion pumps are readily available 10, 11

Task-Shifting Considerations

• In resource-limited settings, 5 grams IM in each buttock (10 grams total) can be given as an emergency loading dose before transfer, as it is better to initiate partial treatment than refer without any magnesium sulfate 10, 11

Magnesium Sulfate Therapy

Special Considerations

• Premature newborns exposed to maternal magnesium sulfate therapy may have elevated magnesium levels in the first days of life, and their low postnatal glomerular filtration rates during the first week limit their ability to excrete excessive magnesium, therefore, magnesium intakes must be limited in newborns of mothers who received magnesium sulfate before delivery, with dosing adapted to postnatal blood concentrations 12

Magnesium Sulfate Administration Guidelines

Indications and Dosing

• Torsades de pointes / polymorphic ventricular tachycardia: Administer 2 g magnesium sulfate intravenously over several minutes as first‑line therapy, regardless of the patient’s serum magnesium level; the American Heart Association recommends a dose of 25–50 mg/kg (maximum 2 g) given rapidly in pediatric patients. 13

Safety Precautions

• Readiness for magnesium toxicity: Calcium gluconate should be immediately available to reverse potential magnesium‑induced toxicity. 14
• Monitoring during rapid infusion: Continuous electrocardiographic monitoring is mandatory while delivering a rapid magnesium sulfate bolus. 14
• Defibrillation preparedness: A defibrillator must be on hand whenever magnesium sulfate is used to treat arrhythmias. 14

Administration Technique

• IV site selection and flush: Use the most proximal intravenous access point possible and follow the magnesium sulfate bolus with an immediate normal‑saline flush to ensure optimal drug delivery. 14

Magnesium Sulfate Dosing for Torsades de Pointes

Recommended Dose and Infusion Rate

• The American Heart Association (as reported in Circulation 2010) recommends a loading dose of 1–2 g of magnesium sulfate administered intravenously over 15 minutes for the treatment of torsades de pointes; a 4‑g dose would be considered excessive unless given as repeated administrations. 15

Safety Considerations of Higher Doses

• According to the same AHA guidance, administering 4 g of magnesium sulfate over one hour exceeds the standard recommendation for torsades de pointes and may increase the risk of toxicity without additional therapeutic benefit. 15

Intravenous Magnesium Sulfate for Severe QT‑Prolongation (QTc ≈ 600 ms)

Adult Immediate Therapy

Dosing Details

Guideline Recommendation & Rationale

Expected Outcomes & Mechanistic Insight

Adverse Effects to Monitor

Pediatric Dosing Adjustment

Timing of 24‑Hour Magnesium Sulfate Maintenance in the Pritchard Regimen

Loading Dose

• The Pritchard protocol begins with a combined 14‑gram loading dose consisting of 4 g intravenous magnesium sulfate administered first, followed simultaneously by 10 g intramuscular (5 g in each buttock). This loading dose rapidly achieves therapeutic serum magnesium concentrations. 19

Maintenance Dosing Schedule

• After the loading dose, 5 g intramuscular magnesium sulfate is given every 4 hours in alternating buttocks, continuing for a total of 24 hours.
• The 24‑hour clock starts at the completion of the loading dose, not at the time of the first maintenance dose; therefore the maintenance period does not reset with each subsequent dose. 19

Clinical Rationale for Timing

• The maintenance interval is calculated from the loading dose because therapeutic magnesium levels are established immediately after the loading dose, and the subsequent doses are intended only to sustain that level throughout the prophylactic 24‑hour window. 19

Common Pitfall to Avoid

• Do not restart the 24‑hour clock with each maintenance dose. Counting 24 hours from the first maintenance dose (administered 4 hours after loading) would extend therapy to 28 hours, exceeding the evidence‑based protocol and increasing unnecessary magnesium exposure. The Pritchard regimen’s timing was validated in the MAGPIE randomized trial, which defined the 24‑hour period as beginning at the loading dose. 19

Modification for Resource‑Limited Settings

• In emergencies where immediate transfer is required, give an emergency loading dose of 10 g intramuscular magnesium sulfate (5 g in each buttock) before transport. This partial loading dose is preferable to no magnesium sulfate while arranging transfer.
• The receiving facility should then complete the full Pritchard protocol, counting the 24‑hour maintenance period from the time the initial loading dose was administered. 19